Bilateral breast cancer: one disease or two?
- PMID: 1663803
- DOI: 10.1007/BF01961160
Bilateral breast cancer: one disease or two?
Abstract
Our purpose was to determine whether bilateral breast cancer depends upon genetic predisposition to multiple tumors or, alternatively, represents two independent sporadic events. Biological concordance of hormone receptors and histopathology in bilateral tumors, family history of breast cancer, age at diagnosis, and survival were evaluated in 88 patients. The immunoreactivity of paired tumors from 51 patients to six different immunocytochemical markers was compared. Neither histologic patterns nor immunocytochemical reactions showed concordance between bilateral tumors. Absence of concordance (other than for estrogen receptors) and lack of associations with positive family history and early age of onset support an interpretation of independent tumor origins and does not suggest a major role for genetic determinants in the majority of cases of bilateral breast cancer.
Similar articles
-
HER2 as a prognostic factor in breast cancer.Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404. Oncology. 2001. PMID: 11694790 Review.
-
Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.Cancer. 1993 Jun 1;71(11):3552-9. doi: 10.1002/1097-0142(19930601)71:11<3552::aid-cncr2820711115>3.0.co;2-n. Cancer. 1993. PMID: 8098267
-
Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.Breast Cancer Res Treat. 2010 Dec;124(3):677-88. doi: 10.1007/s10549-010-0790-6. Epub 2010 Mar 9. Breast Cancer Res Treat. 2010. PMID: 20213083
-
Luminal B breast tumors are not HER2 positive.Breast Cancer Res. 2008;10(5):404; author reply 405. doi: 10.1186/bcr2134. Epub 2008 Sep 26. Breast Cancer Res. 2008. PMID: 18831725 Free PMC article. No abstract available.
-
[Bilateral breast carcinoma].Nihon Geka Gakkai Zasshi. 1985 Mar;86(3):266-79. Nihon Geka Gakkai Zasshi. 1985. PMID: 2984536 Review. Japanese.
Cited by
-
Molecular cytogenetic investigations of synchronous bilateral breast cancer.J Clin Pathol. 2003 Sep;56(9):660-5. doi: 10.1136/jcp.56.9.660. J Clin Pathol. 2003. PMID: 12944548 Free PMC article.
-
Synchronous Bilateral Breast Cancer With Discordant Receptor Status: Treating One Patient but Two Diseases.World J Oncol. 2023 Jun;14(3):224-229. doi: 10.14740/wjon1603. Epub 2023 Jun 11. World J Oncol. 2023. PMID: 37350805 Free PMC article.
-
Bilateral Metachronous Breast Carcinoma: A Rare Case Report.Int J Appl Basic Med Res. 2018 Apr-Jun;8(2):126-128. doi: 10.4103/ijabmr.IJABMR_384_16. Int J Appl Basic Med Res. 2018. PMID: 29744328 Free PMC article.
-
Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype.Int J Clin Exp Pathol. 2013 Dec 15;7(1):353-63. eCollection 2014. Int J Clin Exp Pathol. 2013. PMID: 24427357 Free PMC article.
-
Comparison of the histopathology and prognosis of bilateral versus unilateral multifocal multicentric breast cancers.World J Surg Oncol. 2014 Aug 20;12:266. doi: 10.1186/1477-7819-12-266. World J Surg Oncol. 2014. PMID: 25143016 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical